Dr Reddys Labs Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Jun-2023	Mar-2023	Dec-2022	Sep-2022	Jun-2022
Gross Sales	6738.40	6296.80	6,770	6305.70	5215.40
Excise Duty	--	--	--	--	--
Net Sales	6738.40	6296.80	6,770	6305.70	5215.40
Other Operating Income	19.50	18.40	19.90	26.10	17.50
Other Income	178.30	146.10	64.60	54.80	863.30
Total Income	6936.20	6461.30	6854.50	6386.60	6096.20
Total Expenditure	4695.80	4781.30	4851.30	4432.90	4291.70
PBIDT	2240.40	1,680	2003.20	1953.70	1804.50
Interest	37.10	35.40	41.80	30.90	34.70
PBDT	2203.30	1644.60	1961.40	1922.80	1769.80
Depreciation	353.30	315.50	323.70	309.20	301.80
Minority Interest Before NP	--	--	--	--	--
Tax	719.70	427.90	309.60	367.40	(290.50)
Deferred Tax	(274.70)	(58.90)	84.20	132	569.50
Reported Profit After Tax	1,405	960.10	1243.90	1114.20	1,189
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	1,405	960.10	1243.90	1114.20	1,189
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	1,405	960.10	1243.90	1114.20	1,189
EPS (Unit Curr.)	84.55	57.79	74.91	67.13	71.64
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	83.30	83.30	83.30	83.20	83.20
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	33.25	26.68	29.59	30.98	34.60
PBDTM(%)	32.70	26.12	28.97	30.49	33.93
PATM(%)	20.85	15.25	18.37	17.67	22.80

QuickLinks for Dr Reddys Laboratories Ltd.